Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Byrne

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Science Immunology|October 24, 2020
Itaconate controls the severity of pulmonary fibrosisPatricia P Ogger, Gesa J Albers, Richard J Hewitt, et al.
Nature Communications|September 27, 2023
Lung extracellular matrix modulates KRT5<sup>+</sup> basal cell activity in pulmonary fibrosisRichard J Hewitt, Franz Puttur, David C A Gaboriau, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2020
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary FibrosisRachele Invernizzi, Benjamin G Wu, Joseph Barnett, et al.
Nature Communications|October 19, 2023
Obesity dysregulates the pulmonary antiviral immune responseMark Almond, Hugo A Farne, Millie M Jackson, et al.
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
ERJ Open Research|January 21, 2026
Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasiaMarissa O'Callaghan, Sarah H Forde, Alessandro N Franciosi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Science Immunology|October 24, 2020
Itaconate controls the severity of pulmonary fibrosisPatricia P Ogger, Gesa J Albers, Richard J Hewitt, et al.
Nature Communications|September 27, 2023
Lung extracellular matrix modulates KRT5<sup>+</sup> basal cell activity in pulmonary fibrosisRichard J Hewitt, Franz Puttur, David C A Gaboriau, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2020
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary FibrosisRachele Invernizzi, Benjamin G Wu, Joseph Barnett, et al.
Nature Communications|October 19, 2023
Obesity dysregulates the pulmonary antiviral immune responseMark Almond, Hugo A Farne, Millie M Jackson, et al.
Science Translational Medicine|September 27, 2019
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosisBenjamin Ng, Jinrui Dong, Giuseppe D'Agostino, et al.
ERJ Open Research|January 21, 2026
Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasiaMarissa O'Callaghan, Sarah H Forde, Alessandro N Franciosi, et al.
Pageof 4